Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0Z6DG
|
||||
| Former ID |
DIB021010
|
||||
| Drug Name |
T13
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [542014] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C23H42NaO6PS
|
||||
| InChI |
InChI=1S/C23H43O6PS.Na/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-23(24)28-22-20-27-19-18-21(22)29-30(25,26)31;/h9-10,21-22H,2-8,11-20H2,1H3,(H2,25,26,31);/q;+1/p-1/b10-9-;/t21-,22+;/m0./s1
|
||||
| InChIKey |
DFEVXZSENXLXQQ-LYOQJJATSA-M
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Lysophosphatidate-3 receptor | Target Info | Agonist | [529681] | |
| Lysophosphatidic acid receptor Edg-2 | Target Info | Agonist | [531119] | ||
| NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
| Pathway Interaction Database | LPA receptor mediated eventslysophospholipid_pathway:LPA receptor mediated events | ||||
| References | |||||
| Ref 529681 | LPA and its analogs-attractive tools for elucidation of LPA biology and drug development. Curr Med Chem. 2008;15(21):2122-31. | ||||
| Ref 531119 | Pharmacological tools for lysophospholipid GPCRs: development of agonists and antagonists for LPA and S1P receptors. Acta Pharmacol Sin. 2010 Sep;31(9):1213-22. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.